Lupin names K B S Anand, Dr Punita Kumar Sinha as independent directors

Published On 2020-08-14 07:02 GMT   |   Update On 2020-08-14 07:02 GMT

Mumbai: Pharma major Lupin Limited has announced the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors. Mr. K.B.S. Anand most recently served as Managing Director and Chief Executive Officer at Asian Paints, India's leading paint company. With a career spanning over four decades at Asian Paints, Mr. Anand worked across manufacturing, sales and...

Login or Register to read the full article

Mumbai: Pharma major Lupin Limited has announced the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.

Mr. K.B.S. Anand most recently served as Managing Director and Chief Executive Officer at Asian Paints, India's leading paint company. With a career spanning over four decades at Asian Paints, Mr. Anand worked across manufacturing, sales and marketing functions. He was nominated as the 'Best CEO - Private Sector' at the Forbes Leadership Awards in 2016 and was awarded the Qimpro Gold Standard in Business for Quality in 2017. He currently serves as an Independent Director on the Board of Marico, Tata Chemicals and Borosil.

Mr. Anand holds a B. Tech in Mechanical Engineering from Indian Institute of Technology (IIT), Mumbai, and a PGDM from Indian Institute of Management (IIM), Kolkata.

Dr. Punita Kumar-Sinha brings significant governance and investment experience across India and North America. In her three decade career, she pioneered some of the first foreign investments into the Indian equity markets in the early 1990s. She founded Pacific Paradigm Advisors, an independent investment advisory and management firm, and was formerly a Senior Managing Director at Blackstone. She serves as an Independent Director for several companies including Infosys, JSW Steel, Blackstone Embassy REIT and Rallis.

Dr. Kumar-Sinha is also on the Board of Governors of the CFA Institute (the premier global association for investment management professionals) and has been awarded the Distinguished Alumni Award from Indian Institute of Technology (IIT), New Delhi. Dr. Kumar-Sinha holds a PhD and a Master's in Finance from the Wharton School, University of Pennsylvania. She received her B. Tech in Chemical Engineering with Distinction from Indian Institute of Technology (IIT), New Delhi. She is a CFA charter holder, a TiE Charter Member, and a member of the Council on Foreign Relations.

Commenting on the appointment, Manju D. Gupta, Chairman, Lupin said, "We are delighted to welcome Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha to our board. With their long and illustrious careers, they bring decades of experience in key areas such as innovation, strategy, capital markets and financial expertise that are crucial to Lupin's future operations and strategy".

Read also: Anand K Appointed As New CEO Of SRL Limited


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News